SCHEMBL9516948

SCHEMBL9516948

O=CCC(c1cc(Cl)cc(Cl)c1)S(=O)(=O)NC(=O)c1ccc(CO)nc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
P4HTM Q9NXG6 3/20 0.37
EGFR P00533 2/20 0.37
MEN1 O00255 1/20 0.36
NPC1 O15118 1/20 0.36
RAB9A P51151 1/20 0.36
KMT2A Q03164 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
CASP3 P42574 7/20 0.34
HDAC6 Q9UBN7 3/20 0.33
FLT1 P17948 1/20 0.33
FLT4 P35916 1/20 0.33
KDR P35968 1/20 0.33
HDAC1 Q13547 2/20 0.33
HDAC4 P56524 1/20 0.33
MAP4K4 O95819 2/20 0.33
ROCK2 O75116 1/20 0.33
RPS6KA5 O75582 1/20 0.33
PRKACA P17612 1/20 0.33
RPS6KB1 P23443 1/20 0.33
MAPK1 P28482 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9519668 0.92 EGFR (0.42) P4HTMEGFRMEN1NPC1RAB9A
SCHEMBL9519311 0.90 P4HTM (0.36) P4HTMEGFRMEN1NPC1RAB9A
SCHEMBL9515632 0.85 MEN1 (0.38) P4HTMMEN1NPC1RAB9AKMT2A
SCHEMBL9515748 0.85 P4HTM (0.39) P4HTMEGFRMEN1NPC1RAB9A
SCHEMBL9516708 0.84 SLC6A9 (0.37) P4HTMMEN1NPC1RAB9AKMT2A
SCHEMBL9516276 0.82 HIF1A (0.39) P4HTMMEN1NPC1RAB9AKMT2A
SCHEMBL9519433 0.81 NAMPT (0.39) HDAC6HDAC1
SCHEMBL9515891 0.81 EGFR (0.41) P4HTMEGFRMEN1NPC1RAB9A
SCHEMBL9517183 0.80 LMNA (0.38) P4HTMMEN1NPC1RAB9AKMT2A
SCHEMBL9516974 0.78 EGFR (0.44) P4HTMEGFRMEN1NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0567997-A1 4- or 5-(sulf)imido- and (sulfon)amidopyridines and their pyridine-N-oxides, process for their preparation and their use as pharmaceutical HOECHST AKTIENGESELLSCHAFT (DE) 1993-11-03 EP disclosed